Transient Worsening of Dysphagia and Dysarthria after Treatment with Botulinum Toxin in Patients with Acquired Brain Injury.

acquired brain injury botulinum toxin dysarthria dysphagia spasticity

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
07 Dec 2023
Historique:
received: 13 10 2023
revised: 30 11 2023
accepted: 06 12 2023
medline: 22 12 2023
pubmed: 22 12 2023
entrez: 22 12 2023
Statut: epublish

Résumé

Although botulinum toxin is widely considered an effective and safe treatment for a variety of neurological conditions (such as disabling spasticity), local or systemic adverse effects have often been reported. This study describes three cases of patients with severe acquired brain injury who were receiving speech therapy for recovering dysphagia and dysarthria but showed worsening of these symptoms after receiving BoNT treatment for motor spasticity. To increase clinicians' knowledge of these adverse effects, we present our cases and explore their significance to avoid major complications such as aspiration pneumonia.

Identifiants

pubmed: 38132007
pii: healthcare11243117
doi: 10.3390/healthcare11243117
pii:
doi:

Types de publication

Case Reports

Langues

eng

Auteurs

Lucia Francesca Lucca (LF)

S. Anna Institute, 88900 Crotone, Italy.

Luisa Spezzano (L)

S. Anna Institute, 88900 Crotone, Italy.

Francesco Bono (F)

Center for Botulinum Toxin Therapy, Neurology Unit, A.O.U. Mater Domini, 88100 Catanzaro, Italy.

Maria Ursino (M)

S. Anna Institute, 88900 Crotone, Italy.

Antonio Cerasa (A)

S. Anna Institute, 88900 Crotone, Italy.
Institute for Biomedical Research and Innovation (IRIB), National Research Council of Italy (CNR), 98164 Messina, Italy.
Pharmacotechnology Documentation and Transfer Unit, Preclinical and Translational Pharmacology, Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.

Francesco Piccione (F)

Unit of Neurorehabilitation, Padua Hospital, University of Padua, 35122 Padova, Italy.

Classifications MeSH